Article type
Year
Abstract
Background: eye-acupuncture (EA), a branch of acupuncture, is a fine-needle puncturing therapy for systemic diseases.
Objectives: this bibliometric analysis aims to provide a comprehensive review of the characteristics of EA for ischaemic or haemorrhagic apoplexy based on clinical studies.
Methods: we collected a total of 195 clinical studies from six databases, China Network Knowledge Infrastructure, Chinese Science and Technology Journal Database, Wanfang Data, SinoMed, PubMed and the Cochrane Library from inception to 31 December 2017. We extracted and analyzed bibliometric information, mainly including study type, characteristics of participants, details of the interventions and comparisons, and outcomes. Data were analyzed descriptively by SPSS software to determine their distribution, median and dispersion range, and interquartile range.
Results: EA was used at different stages, acute stage (n =3 8, 19.49%), recovery (n = 32, 16.41%), sequelae (n = 13, 6.67%) and unclear (n = 112, 57.44%). The most frequent EA points were in upper-jiao region and lower-jiao region. The treatment duration for ischaemic or haemorrhagic stroke was four weeks in most studies. Neurological deficit scale, Modified Barthel index, activities of daily living and Fugl-Meyer assessment scale were the most frequently used for outcome measures.
Conclusions: EA as an adjunctive therapy is effective in the treatment of stroke at acute and recovery stages. The most commonly used intervention in clinical practice is EA combined with other traditional Chinese medicine therapies. The common evaluation outcome is NDS (Neurological Deficit Scale). Because of the low methodological quality of the current articles, further studies on stroke treated by EA are required.
Patient or healthcare consumer involvement: our study covered 108 clinical trials involving 15,466 patients aged from 18 to 96.
Objectives: this bibliometric analysis aims to provide a comprehensive review of the characteristics of EA for ischaemic or haemorrhagic apoplexy based on clinical studies.
Methods: we collected a total of 195 clinical studies from six databases, China Network Knowledge Infrastructure, Chinese Science and Technology Journal Database, Wanfang Data, SinoMed, PubMed and the Cochrane Library from inception to 31 December 2017. We extracted and analyzed bibliometric information, mainly including study type, characteristics of participants, details of the interventions and comparisons, and outcomes. Data were analyzed descriptively by SPSS software to determine their distribution, median and dispersion range, and interquartile range.
Results: EA was used at different stages, acute stage (n =3 8, 19.49%), recovery (n = 32, 16.41%), sequelae (n = 13, 6.67%) and unclear (n = 112, 57.44%). The most frequent EA points were in upper-jiao region and lower-jiao region. The treatment duration for ischaemic or haemorrhagic stroke was four weeks in most studies. Neurological deficit scale, Modified Barthel index, activities of daily living and Fugl-Meyer assessment scale were the most frequently used for outcome measures.
Conclusions: EA as an adjunctive therapy is effective in the treatment of stroke at acute and recovery stages. The most commonly used intervention in clinical practice is EA combined with other traditional Chinese medicine therapies. The common evaluation outcome is NDS (Neurological Deficit Scale). Because of the low methodological quality of the current articles, further studies on stroke treated by EA are required.
Patient or healthcare consumer involvement: our study covered 108 clinical trials involving 15,466 patients aged from 18 to 96.